Trial Information
National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients
Inclusion Criteria:
All patients with cancer present in the clinic, hospital, out patients diagnosed with a
VTE during the 6 previous months. VTE can be symptomatic or asymptomatic, can be located
close to a central line, and of any type (DVT, PE, SVT)
Exclusion Criteria:
- Patient already included in a trial studying antithrombotic therapy
- Patient refusing the study
- Patient under 18 and/or not competent to give informed consent
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Evaluation of the adherence to recommendations of VTE treatment in cancer patients
Outcome Description:
Proportion of patients treated for evolutive VTE according to international recommandations Patients could be hospitalised or could be out patient
Outcome Time Frame:
At baseline (J0)
Safety Issue:
No
Principal Investigator
Marie-Antoinette SEVESTRE, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
CHU d'Amiens
Authority:
France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
Study ID:
Version N°2.0 du 21/03/2011
NCT ID:
NCT01362933
Start Date:
May 2011
Completion Date:
July 2011
Related Keywords:
- Neoplasms
- Venous Thromboembolism
- PE
- DVT
- SVT
- LMWH
- VKA
- international Venous Thromboembolism Recommendations
- Neoplasms
- Thromboembolism
- Venous Thromboembolism
- Venous Thrombosis